Valuation: APT Medical Inc.

Capitalization 32.71B 4.81B 4.09B 3.74B 3.53B 6.59B 454B 6.64B 44.37B 17.3B 218B 18.05B 17.67B 753B P/E ratio 2026 *
32.1x
P/E ratio 2027 * 24.9x
Enterprise value 31.29B 4.6B 3.91B 3.58B 3.38B 6.3B 435B 6.35B 42.43B 16.54B 209B 17.26B 16.9B 721B EV / Sales 2026 *
9.66x
EV / Sales 2027 * 7.4x
Free-Float
52.53%
Yield 2026 *
0.52%
Yield 2027 * 0.85%
1 day-0.85%
1 week-2.21%
Current month-2.21%
1 month-9.84%
3 months+1.41%
6 months-17.95%
Current year-4.38%
1 week 228.39
Extreme 228.39
237.92
1 month 228.39
Extreme 228.39
262.26
Current year 219.48
Extreme 219.48
269.68
1 year 219.48
Extreme 219.48
337.2
3 years 139.64
Extreme 139.6433
337.2
5 years 67.05
Extreme 67.0488
337.2
10 years 67.05
Extreme 67.0488
337.2
Manager TitleAgeSince
Chief Executive Officer 61 31/07/2016
Director of Finance/CFO 58 08/11/2019
Chief Tech/Sci/R&D Officer 61 31/12/2010
Director TitleAgeSince
Chairman 61 30/04/2014
Director/Board Member 63 30/04/2014
Director/Board Member 58 30/06/2013
Change 5d. change 1-year change 3-years change Capi.($)
-0.85%-2.21%-17.83%+40.57% 4.81B
-0.75%-0.95%+8.38%+2.34% 12.67B
-0.11%-0.10%+13.89%-3.22% 9.34B
-0.21%+1.85%+48.12%+29.49% 5.6B
+0.96%+2.81%+1.37%-23.45% 5.57B
+0.91%+2.46%-15.33%-5.96% 4.4B
-1.36%-4.46% - - 3.25B
+6.30%+7.64%+2.93%-74.45% 2.07B
-1.73%+3.73%+8.48%-42.75% 1.69B
-1.43%-0.93%+46.29%+4.03% 1.46B
Average +0.17%+0.20%+10.70%-8.15% 5.09B
Weighted average by Cap. -0.06%-0.02%+9.40%-0.37%

Financials

2026 *2027 *
Net sales 3.24B 476M 405M 370M 349M 652M 44.97B 658M 4.39B 1.71B 21.6B 1.79B 1.75B 74.58B 4.12B 606M 515M 471M 445M 829M 57.2B 836M 5.59B 2.18B 27.48B 2.27B 2.22B 94.86B
Net income 1.02B 150M 128M 117M 110M 206M 14.21B 208M 1.39B 541M 6.82B 564M 552M 23.56B 1.32B 194M 165M 151M 142M 265M 18.3B 268M 1.79B 697M 8.79B 727M 712M 30.34B
Net Debt -1.43B -210M -178M -163M -154M -287M -19.8B -290M -1.93B -754M -9.51B -786M -770M -32.83B -2.25B -331M -281M -257M -243M -453M -31.25B -457M -3.05B -1.19B -15.01B -1.24B -1.22B -51.83B
Logo APT Medical Inc.
APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The Company's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The Company is also engaged in related original equipment manufacturer (OEM) business. The Company distributes its products within domestic market and to overseas markets.
Employees
3,118
Date Price Change Volume
08/05/26 232.61 ¥ -0.85% 1,174,486
07/05/26 234.60 ¥ +0.09% 822,637
06/05/26 234.40 ¥ -1.46% 1,814,805
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
232.61CNY
Average target price
335.39CNY
Spread / Average Target
+44.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688617 Stock